Through IPA, we identified 14 out of 289 canonical pathways that were significantly upregulated in CD34+ MM cells compared to CD34− MM cells, with z-scores greater than 2.0 (Supplementary Table 2), most of which were involved in inflammation and/or immune reactions. This evidence concerns the gene CD34 and Miyoshi myopathy.